Literature DB >> 12826741

Cathepsin D polymorphism in Italian elderly subjects with sporadic late-onset Alzheimer's disease.

Tiziana Ingegni1, Giuseppe Nocentini, Elena Mariani, Liana Spazzafumo, M Cristina Polidori, Antonio Cherubini, Marco Catani, Donatella Cadini, Umberto Senin, Patrizia Mecocci.   

Abstract

Alzheimer's disease (AD) is the most frequent cause of dementia in elderly people. Different pathological pathways have been involved in the development of late-onset AD. Among them, numerous genes have been proposed as pathogenetic factors acting independently or interactively. It has been suggested that the cathepsin D gene (CTSD) is associated with late-onset AD. We analyzed an exonic polymorphism of the CTSD gene [C-->T (Ala-->Val) transition at position 224] in 142 AD patients and 120 controls. Our data indicate no significant association between this polymorphism and the risk of AD. Likewise there was no association between CTSD polymorphism and the apolipoprotein E genotype in the risk of developing AD. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12826741     DOI: 10.1159/000071003

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  2 in total

1.  Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.

Authors:  Y Davidson; L Gibbons; A Pritchard; J Hardicre; J Wren; J Tian; J Shi; C Stopford; C Julien; J Thompson; A Payton; U Thaker; A J Hayes; T Iwatsubo; S M Pickering-Brown; N Pendleton; M A Horan; A Burns; N Purandare; C L Lendon; D Neary; J S Snowden; D M A Mann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

2.  Lack of association between cathepsin D C224T polymorphism and Alzheimer's disease risk: an update meta-analysis.

Authors:  Cuiju Mo; Qiliu Peng; Jingzhe Sui; Jian Wang; Yan Deng; Li Xie; Taijie Li; Yu He; Xue Qin; Shan Li
Journal:  BMC Neurol       Date:  2014-01-15       Impact factor: 2.474

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.